Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The lymph node reticular cell network is a specialized stromal framework composed of fibroblastic reticular cells (FRCs) and extracellular matrix components that organize the internal architecture of the lymph node. This network functions as a physical scaffold for immune cell migration and a conduit system for the rapid transport of lymph-borne small molecules, such as antigens and chemokines, to the T-cell zone (Acton et al., 2014, Nature Reviews Immunology). FRCs within the network are vital for immune homeostasis, as they secrete key chemokines (CCL19, CCL21) and survival factors (IL-7) that regulate the positioning and survival of T cells and dendritic cells (Link et al., 2007, Nature Immunology). In pathological conditions, the reticular network undergoes significant remodeling; for example, chronic inflammation or viral infections like HIV can lead to network fibrosis, which impairs immune reconstitution (Schacker et al., 2002, Journal of Clinical Investigation). Furthermore, the network is often exploited by metastatic cancer cells to facilitate their entry and survival within the lymph node (Lund & Swartz, 2010, Nature Reviews Cancer). While the network itself is a multicellular structure rather than a single drug target, specific molecular components such as podoplanin or chemokine receptors are targeted to modulate immune responses or inhibit metastasis.
Not applicable for a multicellular structure; however, therapeutic interventions may target specific molecular components of the network to modulate immune cell recruitment or prevent fibrosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lymph node reticular cell network (FRC network).